Redeye comments on q.beyond’s Q1 report, showing soft gross profit and EBITDA but also a retained gu...
Administer reports Q1 figures on May 13. We expect a slight topline decline alongside improved profi...
Last week, Roche announced the acquisition of PathAI for up to $ 1.
Xbrane delivered a quiet Q1, showing revenue of SEK17.
Redeye updates on Invisio after Q1-results which were lower than expected, albeit partly due to a on...
Ferroamp reported Q1 sales growth of 74% y-o-y, driven by increased deliveries to Aira and Elvy as w...
Redeye provides an update following Corline’s Q1 2026 report.
Catella's Q1 2026 missed Redeye's already-reduced forecast on AUM, fee/AUM and EBIT, and the share f...
BeammWave’s Q1 keeps the commercialisation story alive, but the share is running ahead of hard evide...
Redeye initiates coverage of KDventures, a uniquely VC-style listed investment company focused on bi...
* Gross margins above its target of 80% * Order book at a record and foundation getting stronger * T...
* Q1e: 3% revenue decline y-o-y * '26e EBITDA toward bottom end of guidance range * Trading ~50% bel...
* Sales up 37% y-o-y as adj. EBITA more than doubled * Continued order momentum drives estimate upgr...
* Memory prices boost system sales in Q2-Q3e *Cost initiatives paying off simultaneously, adj.
Redeye comments on IRLAB's Q1 report and recently announced righs issue.
Redeye raises its forecast following surprisingly strong Q1’26 figures, with record volumes and EBIT...
Q1 NAV per share landed at € 35.29, down from € 36.
Westwing delivered its strongest quarterly growth since 2022, with GMV up 13% yoy to € 135m and reve...
Yesterday, DEMIRE published its Q1’26 results, coming in broadly in linw on both top-line and FFO.
Redeye provides an initial take following the release of Corline’s Q1 2026 report.
BeammWave's Q1 2026 print confirms continued progress towards commercialisation.